ScoreWhy is Zhejiang Shengda Bio-Pharm Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2,670.04%
- The company has been able to generate a Return on Capital Employed (avg) of 2,670.04% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 3.21% and Operating profit at -18.51% over the last 5 years
3
The company has declared Positive results for the last 3 consecutive quarters
- NET PROFIT(Q) At CNY 21.71 MM has Grown at 318.83%
- ROCE(HY) Highest at 3.74%
- RAW MATERIAL COST(Y) Fallen by -2,796% (YoY)
4
With ROE of 3.74%, it has a attractive valuation with a 0.71 Price to Book Value
- Over the past year, while the stock has generated a return of 13.00%, its profits have risen by 303.4% ; the PEG ratio of the company is 0.1
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhejiang Shengda Bio-Pharm Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Shengda Bio-Pharm Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Zhejiang Shengda Bio-Pharm Co., Ltd.
-100.0%
1.75
40.87%
China Shanghai Composite
15.19%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.21%
EBIT Growth (5y)
-18.51%
EBIT to Interest (avg)
-2.52
Debt to EBITDA (avg)
0.27
Net Debt to Equity (avg)
0.07
Sales to Capital Employed (avg)
0.48
Tax Ratio
21.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2,670.04%
ROE (avg)
1,212.89%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
0.71
EV to EBIT
13.99
EV to EBITDA
6.36
EV to Capital Employed
0.67
EV to Sales
1.12
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
4.79%
ROE (Latest)
3.74%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
NET PROFIT(Q)
At CNY 21.71 MM has Grown at 318.83%
ROCE(HY)
Highest at 3.74%
RAW MATERIAL COST(Y)
Fallen by -2,796% (YoY
NET SALES(9M)
Higher at CNY 637.19 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.97%
DEBTORS TURNOVER RATIO(HY)
Highest at 5.7%
PRE-TAX PROFIT(Q)
Highest at CNY 27.74 MM
EPS(Q)
Highest at CNY 0.12
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Zhejiang Shengda Bio-Pharm Co., Ltd.
Net Sales
At CNY 637.19 MM has Grown at 257.15%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 27.74 MM has Grown at 907.43%
over average net sales of the previous four periods of CNY 2.75 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 21.71 MM has Grown at 318.83%
over average net sales of the previous four periods of CNY 5.18 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 27.74 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
EPS
Highest at CNY 0.12
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Highest at 2.97%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 5.7%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Higher at CNY 637.19 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Sales (CNY MM)
Raw Material Cost
Fallen by -2,796% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
